Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
340778 participants
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The way an individual processes a drug is in part determined by their genes, and there is known to be genetic variation between humans in the way drugs are metabolized. The study of the way genes affect a person's response to drugs is known as "Pharmacogenomics."
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Utility of PharmacoGenomics for Reducing Adverse Drug Effects
NCT02081872
Utility of Pharmacogenomic Testing in Patients With Gastrointestinal Disorders
NCT05572593
Preemptive Pharmacogenomics Testing Among Geriatric Patients
NCT05091879
Using Pharmacogenetics to Identify Patients With Polypharmacy at Risk of Medication Adverse Effects
NCT03748355
Trial of Preemptive Pharmacogenetics in Underserved Patients
NCT05141019
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is 2 years of age or older
* Subject is not taking an investigational medication or in a clinical trial that would interfere with participation in the registry
Exclusion Criteria
* Subject (or subject's parent/guardian) is unable to provide an accurate history due to mental incapacity, in the Investigator's opinion.
2 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Companion Dx Reference Lab, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CD-2014-102
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.